Literature DB >> 30150361

Dorsal BNST α2A-Adrenergic Receptors Produce HCN-Dependent Excitatory Actions That Initiate Anxiogenic Behaviors.

Nicholas A Harris1,2, Austin T Isaac1, Anne Günther3,4, Kevin Merkel1, James Melchior1,2, Michelle Xu1, Eghosa Eguakun1,5, Rafael Perez1,6, Brett P Nabit1, Stephanie Flavin1,7, Ralf Gilsbach8, Brian Shonesy1,2, Lutz Hein8,9, Ted Abel10, Arnd Baumann11, Robert Matthews1, Samuel W Centanni1,2, Danny G Winder12,2,13,7,6,3.   

Abstract

Stress is a precipitating agent in neuropsychiatric disease and initiates relapse to drug-seeking behavior in addicted patients. Targeting the stress system in protracted abstinence from drugs of abuse with anxiolytics may be an effective treatment modality for substance use disorders. α2A-adrenergic receptors (α2A-ARs) in extended amygdala structures play key roles in dampening stress responses. Contrary to early thinking, α2A-ARs are expressed at non-noradrenergic sites in the brain. These non-noradrenergic α2A-ARs play important roles in stress responses, but their cellular mechanisms of action are unclear. In humans, the α2A-AR agonist guanfacine reduces overall craving and uncouples craving from stress, yet minimally affects relapse, potentially due to competing actions in the brain. Here, we show that heteroceptor α2A-ARs postsynaptically enhance dorsal bed nucleus of the stria terminalis (dBNST) neuronal activity in mice of both sexes. This effect is mediated by hyperpolarization-activated cyclic nucleotide-gated cation channels because inhibition of these channels is necessary and sufficient for excitatory actions. Finally, this excitatory action is mimicked by clozapine-N-oxide activation of the Gi-coupled DREADD hM4Di in dBNST neurons and its activation elicits anxiety-like behavior in the elevated plus maze. Together, these data provide a framework for elucidating cell-specific actions of GPCR signaling and provide a potential mechanism whereby competing anxiogenic and anxiolytic actions of guanfacine may affect its clinical utility in the treatment of addiction.SIGNIFICANCE STATEMENT Stress affects the development of neuropsychiatric disorders including anxiety and addiction. Guanfacine is an α2A-adrenergic receptor (α2A-AR) agonist with actions in the bed nucleus of the stria terminalis (BNST) that produces antidepressant actions and uncouples stress from reward-related behaviors. Here, we show that guanfacine increases dorsal BNST neuronal activity through actions at postsynaptic α2A-ARs via a mechanism that involves hyperpolarization-activated cyclic nucleotide gated cation channels. This action is mimicked by activation of the designer receptor hM4Di expressed in the BNST, which also induces anxiety-like behaviors. Together, these data suggest that postsynaptic α2A-ARs in BNST have excitatory actions on BNST neurons and that these actions can be phenocopied by the so-called "inhibitory" DREADDs, suggesting that care must be taken regarding interpretation of data obtained with these tools.
Copyright © 2018 the authors 0270-6474/18/388923-21$15.00/0.

Entities:  

Keywords:  HCN channels; alpha2a-adrenergic receptor; anxiety; bed nucleus of the stria terminalis; guanfacine; norepinephrine

Mesh:

Substances:

Year:  2018        PMID: 30150361      PMCID: PMC6191524          DOI: 10.1523/JNEUROSCI.0963-18.2018

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  86 in total

1.  Distributions of mRNAs for alpha-2 adrenergic receptor subtypes in rat brain: an in situ hybridization study.

Authors:  A P Nicholas; V Pieribone; T Hökfelt
Journal:  J Comp Neurol       Date:  1993-02-22       Impact factor: 3.215

2.  Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication.

Authors:  Ronald C Kessler; Patricia Berglund; Olga Demler; Robert Jin; Kathleen R Merikangas; Ellen E Walters
Journal:  Arch Gen Psychiatry       Date:  2005-06

3.  Treatment of cocaine withdrawal anxiety with guanfacine: relationships to cocaine intake and reinstatement of cocaine seeking in rats.

Authors:  Deanne M Buffalari; Chelsey K Baldwin; Ronald E See
Journal:  Psychopharmacology (Berl)       Date:  2012-04-18       Impact factor: 4.530

4.  Rigid analogues of the α2-adrenergic blocker atipamezole: small changes, big consequences.

Authors:  Bernard Vacher; Philippe Funes; Philippe Chopin; Didier Cussac; Peter Heusler; Amelie Tourette; Marc Marien
Journal:  J Med Chem       Date:  2010-10-14       Impact factor: 7.446

5.  Characterization of the alpha-2C adrenergic receptor subtype in the opossum kidney and in the OK cell line.

Authors:  H S Blaxall; T J Murphy; J C Baker; C Ray; D B Bylund
Journal:  J Pharmacol Exp Ther       Date:  1991-10       Impact factor: 4.030

Review 6.  Pharmacological treatment of alcohol dependence: target symptoms and target mechanisms.

Authors:  Markus Heilig; Mark Egli
Journal:  Pharmacol Ther       Date:  2006-03-20       Impact factor: 12.310

Review 7.  50 years of hurdles and hope in anxiolytic drug discovery.

Authors:  Guy Griebel; Andrew Holmes
Journal:  Nat Rev Drug Discov       Date:  2013-09       Impact factor: 84.694

Review 8.  Alcohol Effects on Stress Pathways: Impact on Craving and Relapse Risk.

Authors:  Sara K Blaine; Verica Milivojevic; Helen Fox; Rajita Sinha
Journal:  Can J Psychiatry       Date:  2016-02-09       Impact factor: 4.356

9.  Parallel, but Dissociable, Processing in Discrete Corticostriatal Inputs Encodes Skill Learning.

Authors:  David A Kupferschmidt; Konrad Juczewski; Guohong Cui; Kari A Johnson; David M Lovinger
Journal:  Neuron       Date:  2017-10-11       Impact factor: 17.173

10.  Alpha2A-adrenoceptors are important modulators of the effects of D-amphetamine on startle reactivity and brain monoamines.

Authors:  Janne Lähdesmäki; Jukka Sallinen; Ewen MacDonald; Mika Scheinin
Journal:  Neuropsychopharmacology       Date:  2004-07       Impact factor: 7.853

View more
  13 in total

1.  α2A-adrenergic heteroreceptors are required for stress-induced reinstatement of cocaine conditioned place preference.

Authors:  Rafael E Perez; Aakash Basu; Bretton P Nabit; Nicholas A Harris; Oakleigh M Folkes; Sachin Patel; Ralf Gilsbach; Lutz Hein; Danny G Winder
Journal:  Neuropsychopharmacology       Date:  2020-02-19       Impact factor: 7.853

2.  BNST GluN2D-Containing NMDA Receptors Influence Anxiety- and Depressive-like Behaviors and ModulateCell-Specific Excitatory/Inhibitory Synaptic Balance.

Authors:  Gregory J Salimando; Minsuk Hyun; Kristen M Boyt; Danny G Winder
Journal:  J Neurosci       Date:  2020-04-10       Impact factor: 6.167

3.  mGlu2 and mGlu3 Negative Allosteric Modulators Divergently Enhance Thalamocortical Transmission and Exert Rapid Antidepressant-like Effects.

Authors:  Max E Joffe; Chiaki I Santiago; Kendra H Oliver; James Maksymetz; Nicholas A Harris; Julie L Engers; Craig W Lindsley; Danny G Winder; P Jeffrey Conn
Journal:  Neuron       Date:  2019-11-14       Impact factor: 17.173

Review 4.  Corticotropin releasing factor and norepinephrine related circuitry changes in the bed nucleus of the stria terminalis in stress and alcohol and substance use disorders.

Authors:  Angela E Snyder; Yuval Silberman
Journal:  Neuropharmacology       Date:  2021-10-06       Impact factor: 5.250

5.  Disruption of Synaptic Transmission in the Bed Nucleus of the Stria Terminalis Reduces Seizure-Induced Death in DBA/1 Mice and Alters Brainstem E/I Balance.

Authors:  Maya Xia; Benjamin Owen; Jeremy Chiang; Alyssa Levitt; Katherine Preisinger; Wen Wei Yan; Ragan Huffman; William P Nobis
Journal:  ASN Neuro       Date:  2022 Jan-Dec       Impact factor: 5.200

6.  Noradrenergic Signaling Disengages Feedforward Transmission in the Nucleus Accumbens Shell.

Authors:  Kevin M Manz; Benjamin C Coleman; Carrie A Grueter; Brenda C Shields; Michael R Tadross; Brad A Grueter
Journal:  J Neurosci       Date:  2021-03-18       Impact factor: 6.167

7.  The first identification of nesfatin-1-expressing neurons in the human bed nucleus of the stria terminalis.

Authors:  Artur Pałasz; Katarzyna Bogus; Aleksandra Suszka-Świtek; Andrzej Kaśkosz; Shirley Saint-Remy; Aneta Piwowarczyk-Nowak; Łukasz Filipczyk; John J Worthington; Kinga Mordecka-Chamera; Karol Kostro; Grzegorz Bajor; Ryszard Wiaderkiewicz
Journal:  J Neural Transm (Vienna)       Date:  2019-02-15       Impact factor: 3.575

8.  Cocaine Augments Dopamine Mediated Inhibition of Neuronal Activity in the Dorsal Bed Nucleus of the Stria Terminalis.

Authors:  J R Melchior; R E Perez; G J Salimando; J R Luchsinger; A Basu; D G Winder
Journal:  J Neurosci       Date:  2021-05-20       Impact factor: 6.167

9.  Delineation of an insula-BNST circuit engaged by struggling behavior that regulates avoidance in mice.

Authors:  Joseph R Luchsinger; Tracy L Fetterly; Kellie M Williford; Gregory J Salimando; Marie A Doyle; Jose Maldonado; Richard B Simerly; Danny G Winder; Samuel W Centanni
Journal:  Nat Commun       Date:  2021-06-11       Impact factor: 14.919

10.  Cyclooxygenase-2 inhibition prevents stress induced amygdala activation and anxiety-like behavior.

Authors:  Amanda Morgan; Andrew Gaulden; Megan Altemus; Kellie Williford; Samuel Centanni; Danny Winder; Sachin Patel
Journal:  Brain Behav Immun       Date:  2020-08-04       Impact factor: 19.227

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.